Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity. | Indian J Med Res | 2016 | 28474630 | PubTator, text mining | PubMed |
| First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors. | Pan Afr Med J | 2016 | 28292129 | PubTator, text mining | PubMed |
| Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer. | Lung Cancer (Auckl) | 2016 | 28210165 | PubTator, text mining | PubMed |
| Development and progress for three decades in umu test systems. | Genes Environ | 2016 | 27980699 | PubTator, text mining | PubMed |
| CYP2D6 polymorphisms and their influence on risperidone treatment. | Pharmgenomics Pers Med | 2016 | 27942231 | PubTator, text mining | PubMed |
| Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus. | Rev Bras Reumatol Engl Ed | 2016 | 27914600 | PubTator, text mining | PubMed |
Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene Polymorphism rs1989839 is Associated with Risk and Metastatic Potential of Osteosarcoma in Young Chinese Individuals: A Multi-Center, Case-Control Study. | Med Sci Monit | 2016 | 27880743 | PubTator, text mining | PubMed |
| An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma. | J Cancer | 2016 | 27877219 | PubTator, text mining | PubMed |
| Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil. | Tuberculosis (Edinb) | 2016 | 27865386 | PubTator, text mining | PubMed |
| Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis. | BMC Infect Dis | 2016 | 27835982 | PubTator, text mining | PubMed |
| Abstracts from the 16th International Congress on Circumpolar Health. | Int J Circumpolar Health | 2016 | 27829488 | PubTator, text mining | PubMed |
| Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters. | Genome Med | 2016 | 27825374 | PubTator, text mining | PubMed |
| A prospective multicenter study on bladder cancer: the COBLAnCE cohort. | BMC Cancer | 2016 | 27809812 | PubTator, text mining | PubMed |
| Female with bladder cancer: what and why is there a difference? | Transl Androl Urol | 2016 | 27785424 | PubTator, text mining | PubMed |
| New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong? | Onco Targets Ther | 2016 | 27785053 | PubTator, text mining | PubMed |
| Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer. | Int J Mol Sci | 2016 | 27754415 | PubTator, text mining | PubMed |
| A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground. | Clin Infect Dis | 2016 | 27742637 | PubTator, text mining | PubMed |
| Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development. | Genes Cancer | 2016 | 27738493 | PubTator, text mining | PubMed |
| NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients. | Int J Tuberc Lung Dis | 2016 | 27725049 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease. | Immunol Allergy Clin North Am | 2016 | 27712769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=69